Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Clinical Investigation
Randomized Crossover Study of the Long-Term Effects of Pilsicainide and Cibenzoline in Preventing Recurrence of Symptomatic Paroxysmal Atrial Fibrillation
Influence of the Duration of Arrhythmia Before Therapy
Takashi KomatsuYoshihiro SatoHideaki TachibanaMotoyuki NakamuraDaisuke HoriuchiKen Okumura
Author information
JOURNAL FREE ACCESS

2006 Volume 70 Issue 6 Pages 667-672

Details
Abstract

Background There is little information on the selection of antiarrhythmic agents for long-term prevention of paroxysmal atrial fibrillation (PAF). In the present study the preventive effects of pilsicainide (Pil) and cibenzoline (Cib) were compared in patients with PAF that was defibrillated at <48 h or ≥48 h after onset. Methods and Results A total of 60 patients (45 men, 15 women, mean age 66±10 years) were divided into 2 groups: Group I consisted of 22 patients in whom atrial fibrillation (AF) lasted for <48 h before cardioversion and Group II consisted of 38 patients in whom AF lasted for ≥48 h. A randomized, crossover protocol of treatment with Pil (150 mg/day) and Cib (300 mg/day) was used. Mean follow-up was 35±18 months. In Group I, the mean duration of maintenance of sinus rhythm was 12.3±2.9 months in patients treated with Pil, compared with 12.9±2.5 months in those givem Cib (p=NS between 2 groups). Actuarial event-free rates at 1, 3, 6, 12 months were 82%, 68%, 59% and 41%, respectively, in patients treated with Pil, and 91%, 77%, 68% and 50%, respectively, in those givenh Cib (p=NS between 2 groups). In Group II, the mean duration of maintenance of sinus rhythm was 1.6±0.5 months in patients treated with Pil, compared with 5.9±1.7 months in those given Cib (p<0.01). Actuarial event-free rates at 1, 3, 6, 12 months were 45%, 18%, 8% and 3%, respectively, in patients treated with Pil, and 63%, 45%, 29% and 16%, respectively, in those given Cib (p<0.05, at 12 months). Conclusions Prolonged tachycardia (≥48 h) in patients with PAF seems to cause electrical remodeling. Cib, a multichannel blocker, is considered to be more effective in preventing the recurrence of PAF in the electrically remodeled atria than Pil, a pure sodium-channel blocker. (Circ J 2006; 70: 667 - 672)

Content from these authors
© 2006 THE JAPANESE CIRCULATION SOCIETY
Previous article Next article
feedback
Top